Beyond The Bench

Current Protocols Editors’ Forum

Subscribe to the Beyond the Bench RSS Feed

Archive for May, 2009

Genes Under Law

Friday, May 29th, 2009

If you had a gene that could cause a fatal disease, you would want to know, right? And therefore, if some piece of legislation were in the way of your being able to find out, you would obviously want it changed. This premise is what has led to a recent lawsuit, in which The American Civil Liberties Union (ACLU) and the Public Patent Foundation (PUBPAT)—on behalf of women’s health groups, individual women, and numerous scientific associations—have challenged the constitutionality of gene patents held by Myriad Genetics and the University of Utah Research Foundation. Currently, 20% of human genes have been patented; however, the genes in this particular case have proven to play roles in hereditary breast and ovarian cancers. The fact that research and diagnoses may be hindered by their being patented is what has brought the lawsuit.
genestrand2

By patenting these genes, Myriad retains exclusive rights to perform diagnostic tests on BRCA1 and BRCA2, as well as rights to future mutations discovered on the BRCA2 gene. The lawsuit against Myriad et al. alleges that such exclusive control over these genes both impedes and discourages scientific research. With access to the gene initially blocked and guaranteed loss of rights to any findings, what would motivate a researcher to investigate these genes?

Furthermore, the lawsuit argues that Myriad’s monopolistic control over BRCA1 and BRCA2 hampers clinical diagnosis. Myriad charges $3,000 for its diagnostic cancer test—a price that many women cannot afford. For those patients who can pay, they are prohibited from getting second opinions or seeking additional testing elsewhere because, by law, only Myriad has access to these genes.

The lawsuit against Myriad argues that the company has patented the association between mutations conferring an increased risk of breast or ovarian cancer—in effect, patenting an idea, scientific fact, or piece of knowledge. “That’s a violation of the First Amendment,” says Tania Simoncelli, an advisor to ACLU, “because [it's as if] the government has issued a patent on thought or knowledge.” Yet, what the lawsuit essentially boils down to is the question of whether capitalism is getting in the way of moral obligations and constitutional rights. What information should be morally permissible to restrict (in this case, through patenting)? Do human genes deserve special status?

“Patents are meant to protect inventions, not things that exist in nature,” says Chris Hansen, an attorney for ACLU. Likewise, Daniel Ravicher, Executive Director of PUBPAT follows that, “Genes are identified, not invented, and patenting genetic sequences is like patenting blood, air, or e=mc2”. However, no one has challenged patents on other organisms genes or “natural substances” (purified forms of antibiotics that exist naturally in fungi, for instance). Thus, the assumption is that the human genome is “sacred.”

For further reading on this interesting and controversial subject:

Ask an Expert!

Tuesday, May 26th, 2009

scientist_questionHaving trouble with an experiment? Wondering what protocol to use? Simply curious about recent news in Molecular or Cell Biology?

Our CP expert Manos Mavrakis is ready and available to answer your questions!

Check out his latest topic on the Molecular and Cell Biology: Ask the Expert forum: “GFP glows gold”. If you aren’t well-informed about this green fluorescent protein or are curious about pursuing resultant fluorescence-based techniques in your lab, Dr. Mavarkis is eager and willing to proffer his knowledge!

NIH wants your input!

Friday, May 22nd, 2009

In their May Pulse Newsletter, the International Society for Stem Cell Biology (ISSCR) urged researchers to comment on the NIH draft guidelines for the federal funding of human embryonic stem cell research. The draft, released on April 17, is open to public comment until May 26, 2009. A template letter has been created to help in responding to the NIH. The letter references key points in the NIH draft guidelines and refers back to the ISSCR’s Guidelines.

The NIH reports they have already received more than 7,000 comments, but very, very few from the scientific community. The ISSCR urges you to comment on the guidelines and reiterate the need for expanded federal support of human embryonic stem cell research. The society will make its comments available on the ISSCR Web site in advance of the deadline.

View the NIH draft guideline View template response letter Submit comments to NIH

The Controversy Over Biofuel

Wednesday, May 20th, 2009

biofuelcornThe very term “biofuel” seems to imply an automatic environmental gold star. These gas or liquid fuels, made from plant material, are distinguishable from fossil fuels because biofuels are renewable, while fossil fuels are not. Thus, biofuels are lauded as environmentally sustainable because of this renewable (replantable!) quality, and also as environmentally friendly because they should, purportedly, reduce greenhouse gases. Plants absorb carbon dioxide as they grow, so by using them as fuel, we are essentially creating a sponge-like system that “soaks up” and “wrings out” carbon dioxide, rather than continuing to twist the nozzle on the faucet that has been dumping carbon dioxide into our atmosphere for over a century.

However, according to research by scientists such as David Pimentel, these biofuels don’t actually act like sponges at all. Biofuels are created out of plants, so the greater the demand for biofuels, the greater the demand for the plants (e.g. corn, sugarcane, palm trees, switchgrass) used to make them. As the demand for these plants increases, the demand for land on which to grow them will increase, too. Then, because farmers will still need land on which to plant consumable crops, they will need to clear more land for these “new” plants—a process that will, according to many researchers, have devastating consequences.

To provide such a substantial amount of biofuel, a substantial amount of biofuel crops would need to be grown. One argument is that these can be grown on “wastelands,” which will make better use of otherwise worthless land. Mary Gardiner, a post-doc studying with Doug Landis, an ecological entomologist at Michigan State University, investigated the impact of growing biofuel crops upon biodiversity and discovered—somewhat unsurprisingly—that mono-cultures (e.g. all-corn plots) support less insect and avian diversity than even degraded or marginal prairies. The bottom line is that there really aren’t such things as “wastelands.” “You hear a lot about using ‘marginal lands’ and ‘waste wood,’ but that land and debris is still somebody’s habitat,” says Landis. Moreover, a team of researchers from MIT used a computer model to project what the global landscape will be in 2050 if cellulosic fuels (new types of biofuel that are created by breaking down plants’ cellulose) are used to provide 10% of the world’s energy. The study concluded that “many areas would lose from 20-70% of their natural habitats,” which would be particularly injurious to such biodiverse areas as Mesoamaerica, Brazil, Guinea/West Africa, Madagascar, Malaysia, and Indonesia.

In addition to diminishing biodiversity, a second and equally detrimental consequence of clearing land in order to plant biofuel crops is that this phsyical act will actually increases carbon emissions. This is due to the fact that plants and soil store three times as much carbon as air does. “Cut down forests, burn them, churn the soil,” says Joseph Fargione, who makes this argument in his paper Land Clearing and the Biofuel Carbon Debt, “and you release all the carbon that’s been stored.” Furthermore, biofuel crops are actually less effective at absorbing carbon than the natural forests or grasslands they may be replacing. A 1999 study by Cheryl Palm, a Senior Research Scientist at the Earth Institute’s Tropical Agriculture Program, found that plantations are capable of storing only 20% of the carbon that intact forests can store. This means that for every forest that is torn down and replaced by a corn or switchgrass field, 80% of the carbon that was being absorbed by that forest is now being left to linger in our atmosphere and contribute to global warming.

As has been the answer in the past, the best approach to sustainability still seems to be conservation. Use less; save more. Less automotive transportation will decrease greenhouse gas emissions—end of story. Also (and perhaps less intuitively), taxing meat consumption would reduce the clearing of land for crops. If we only grew food we needed to eat (i.e. became vegetarians), we could reduce the amount of land we use for crop growth by 90%—leaving that much more land for fields of biofuel crops…. Or perhaps we should just start looking for alternative sources of fuel.

Star Trek Science

Thursday, May 14th, 2009

startrekmovie2009The new Star Trek film is out, and with all that intergalactic space-time mumbo jumbo floating around, now seems an appropriate time to separate fact from fiction. After all, some of the “futuristic” technology is clearly available today. “Communicators?” We have iPhones. “Universal translation devices?” Although they may turn out some muddled results, Google Translator and Yahoo! Babel Fish can accomplish the basics.

A more surprising device that actually existed before the Star Trek series began is the “hypospray,” or, as it is called in our world, the jet-injector. These devices inject medicine into the body using high-pressure jets of liquid instead of needles. They were first patented in 1960—the first episode of Star Trek aired in 1966—in order to administer mass vaccinations. Why aren’t they more popular today? Most likely because needles work just as well, and jet-injections are significantly more expensive.

Now, on to the more exciting gadgets. While we don’t have guns that can instantly vaporize human beings (these would require too much heat and energy), phasers are essentially energy-directed weapons—which we have developed, in the form of lasers. One example of a modern-day laser is the long-range tactical laser cannon, which is in final development under the US Air Force and Boeing. On August 7, 2008, the C-130H aircraft fired a beam that successfully destroying a three-by-three-foot target on the ground. This weapon is being developed for defensive tactics; it will knock out missiles by emitting the heat of a blowtorch at a distance of 20km.

Alternatively, the military might avoid enemy fire in the first place by evading detection through the use of Star Trek’s cloaking devices. And indeed, they are working on it! The latest research, published by researchers at Duke University in the January issue of Science, uses an algorithm, metamaterials, and electromagnetic radiation to produce a 20” X 4” cloak. The cloak works by bending light around its materials, effectively making them invisible. The technology has not yet advanced to being able to cloak against every wavelength, nor can it make a cloak the size of, say, a spaceship, but as is evidenced by the recent results from Duke (research which was supported by sponsors such as Raytheon Missile Systems and the Air Force Office of Scientific Research), these developments are no doubt underway.

startrek-teleportLast but certainly not least, we must address transporters—or, as they are more popularly known, teleporters. In Star Trek, teleportation works by disassembling a person down to the atomic level, converting them into energy, and then “beaming” them to the new location. In reality, however, there are several issues with this concept. First of all, disassembling a human being at the atomic level would require heating them up to a billion degrees. Then, turning those particles into energy would require energy equivalent to something along the lines of a 1,000 megaton nuclear weapon—not exactly practical if this technology is intended for mass transportation. Finally, Star Trek’s method of teleportation is receiverless—that is, no device is necessary to deposit the particles at their destination so long as a “signal” is available. However, according to the theory of quantum teleportation—which does exist in modern-day reality—a receiver would be necessary at the other end of the “trip.”

The modern concept of quantum teleportation involves sending our essential information, or “quantum state,” elsewhere. The problem with teleporting a human, however, is our size and our complexity. To teleport an object, its quantum state must be measured at the subatomic level. The average person is made up of more than 1027* atoms, which are in turn made up of all sorts of subatomic particles (i.e. protons, neutrons, electrons, etc.). Measuring all of these particles would not only take a very long time, but assembling them into their precise quantum state (i.e. you as opposed to your next-door-neighbor Sally, her dog Fido, or the rock in her front yard) is not something that is likely to be feasible in the near future.

If you’re interested in knowing more about the science of Star Trek, check out Lawrence Krauss’s book The Physics of Star Trek. As a theoretical physicist at Arizona State University’s School of Earth & Space Exploration, he gives some valuable insights in a recent interview with Scientific American, as well.

* 10,000,000,000,000,000,000,000,000,000

CP Authors to be Inducted into National Academy of Sciences

Wednesday, May 13th, 2009

Last month the US National Academy of Sciences announced the list of new members to be inducted in 2009.  The NAS currently includes about 2,100 members and 350 foreign associates (scientists based outside the US), recognized for significant achievement in their fields.  New members are elected by current members for lifetime terms, during which they serve as “advisors to the nation on science, engineering, and medicine.”

Election to the NAS is a tremendous  honor for scientists, not far off from the Nobel Prize (and about 200 NAS members have one of those, too).   This year, four scientists who have written for Current Protocols are among the inductees, one as a member and three as foreign associates.  We’d like to congratulate them on this prestigious accomplishment, and take this opportunity to share a little bit about their distinguished careers.

 

Shizuo Akira

Dr. Akira is director of the Immunology Frontier Research Center at Osaka University in Japan.  His ground-breaking work in immunology is focused mainly on innate host defense mechanisms; he is particularly known for his discoveries concerning toll-like receptor genes, showing that TLRs can recognize pathogenic molecules in the host and initiate an antimicrobial response.  He is one of the world’s most-cited scientists, having published around 300 papers in his career.

http://en.wikipedia.org/wiki/Shizuo_Akira

CP Immunology unit 14.12 – Toll-Like Receptors

 

Pascale Cossart

A renowned bacteriologist, Dr. Cossart is director and head of the Unite des Interactions Bacteries Cellules at the Pasteur Institute of Paris.  She is the world’s top authority on the pathogen Listeria monosytogene, an infectious bacterium responsible for many types of illnesses.  Her research has helped to improve understanding of how this pathogen functions, knowledge that can be applied to bacterial infections in general and used to develop treatment of deadly diseases.

http://en.wikipedia.org/wiki/Pascale_Cossart

CP Microbiology unit 9B.1 – Animal Models of Listeria Infection

 

Sandra Díaz

Dr. Díaz specializes in functional biodiversity and its impact on global ecosystems.  She is an associate professor at the Istituto Multidisciplinario de Biología Vegetal in Córdoba, Argentina, where her team has contributed greatly to the field of biodiversity regulation of ecosystem services.  She is responsible for developing Latin America’s most comprehensive plant trait database.

www.ecosystem-services.org

CP Immunology unit 8.13 - Metabolic Radiolabeling of Animal Cell Glycoconjugates (also published in CP Molecular Biology and CP Protein Science)

 

Kevan Shokat

In his lab at the Hughes Research Center at the University of California – San Francisco, Dr. Shokat researches the cellular signaling functions of individual kinases in the body to determine which kinases should be targeted in treating cancer and other diseases.  The Shokat Lab focuses primarily on chemistry tools and methods, generating models to illustrate how information is transmitted in healthy and diseased organisms.

http://shokatlab.ucsf.edu/Research.htm

CP Molecular Biology unit 18.11 – Design and Use of Analog-Sensitive Protein Kinases

 

Read the National Academy of Sciences press release announcing the new members

Snowball: a scientific rockstar

Wednesday, May 6th, 2009

SnowballWith Paula Abdul hogging the limelight and swines taking over the press, Snowball has had to find another way into mainstream media. Luckily, he has YouTube videos and science journals to help him.

In October 2007, Snowball, a 12-year old sulphur-crested cockatoo, made his debut on YouTube, performing what seemed to be synchronized head bobs, foot lifts, and side-to-side swaying on a video entitled ”Snowball—Our Dancing Cockatoo”. Shortly after its posting, Aniruddh Patel, a Senior Fellow at The Neurosciences Institute, discovered the video. Patel has argued that the ability to move synchronously to a rhythmic beat (i.e. dance) is linked with the ability to learn and mimic sounds (i.e. speak), but the video still stunned him. Along with colleagues John Iversen, Micah Bregman, Irena Schulz, and Charles Schulz, Patel decided to further investigate Snowball’s talents.

What we perceive as singing and dancing—and scientists refer to as “beat perception and synchronization” (BPS)—is significantly more complex in humans than in other seemingly “musical” animals. Crickets, for example, can produce periodic signals in synchrony, but humans can synchronize to more complex rhythms, can sync across a wide range of tempi, and can synch with an auditory stimulus that drives motor production without intending to produce (i.e. dancing, as opposed to singing/chirping/croaking/etc.). In a 2006 study, Patel argued that because BPS requires a tight integration between the auditory and motor systems, only brains capable of complex vocal learning should be capable of BPS. Humans are, obviously, one such species; parrots are another.

In order to determine whether Snowball was actually performing BPS of his own accord, Patel and his team conducted two rounds of experiments in which they tested whether the cockatoo could adjust his “dancing” to match eleven different musical tempi. They were careful to suppress all rhythmic movements, so as not to influence the bird, and they did not reward him. Lo and behold, as soon as the Backstreet Boys’ song “Everybody” began playing, Snowball started to dance!

Patel’s team then analyzed the videos for synchrony between Snowball’s head-bobs and “Everybody’s” musical beat. Results revealed synchrony, particular at faster tempi, which led the researchers to conclude that BPS is a latent ability in certain types of brains (those capable of vocal learning) and did not develop as a brain specialization for music (because parrots do not make music).

Still, as with all scientific research, there are outstanding questions. Snowball didn’t synchronize well at slower tempi, nor did he synchronize for long periods of time even during faster tempi. Could limited attention or motor capabilities be the restrictive factors? Or might Snowball have a “preferred tempo” that is only impacted weakly by the impeding musical tempo? Further research with a larger sample size will help to answer these questions.

Ultimately, Patel hopes his research will lead to ways of assisting people with Parkinson’s disease. “To actually do research at the neurological level of how rhythmic sounds can drive the motor system—that could ultimately help us understand how it’s helping these people and help us treat them better.”

Read More:

Scientists Gunning for NIH Grant Money

Monday, May 4th, 2009

The word “stimulus” has enjoyed disproportionate exposure in the past few months.  Lately it is regarded with some cynicism, as an extravagant approach to a messy problem; the government has so far “stimulated” the auto industry, banks, and taxpayers, with varying degrees of attendant controversy.  But one stimulus that many of us agree was long overdue is the new funding to be provided for biomedical research.  The Obama administration will provide $10.4 billion for NIH research projects, and thousands of scientists desperately in need of funding are scrambling to get their share.

Government grants have always been competitivesometimes discouragingly so.  Countless researchers have spent much of their precious time working on applications that are subsequently rejected.  The process is often slow and painfully bureaucratic; even a successful application can be frustrating if it takes too long to translate into actual cash.  With the new stimulus, the process promises to accelerate (the government will review thousands of applications this year to dole out the money as quickly as possible), but the level of competition has become more frenetic than ever.

So ravenous for funding are these scientists that they have all but halted their actual research in order to focus on their applications.  This spring, faculty members at one institution are estimated to spend 75 to 90 percent of their time in pursuit of government grants.  The endless paperwork and incidental lack of research productivity, while difficult in the short term, can lead to a huge payoff for any industrious scientist who is rewarded with a chunk of this enormous stimulus package.  So how does a researcher, especially one with no preëxisting NIH funding, increase his or her chances of success?

Collaboration is key.  In addition to working on proposals, scientists are frantically working to assemble teams for the projects they hope to undertake if the NIH gods are willing.  One grant in particular is generating a lot of excitement: the NIH Challenge Grant, worth $200 million, has received a huge number of applications because it is relatively attainable for smaller, less established labs with promising research, although teams that are well-connected to the NIH still have a significant advantage.

Above all, the objective of this flurry of new funding is to produce real solutions in biomedical fields; the Challenge Grant will be awarded to 200 teams whose research will address particular health challenges outlined by the government, such as HIV treatment.  As of April 27th the deadline for Challenge Grant applications has passed, but several more grants are still open, and hopefuls will continue their feverish proposal-writing throughout 2009.

If all goes according to plan, the grant-funded research should be underway and producing results over the next year or so.  We may soon be seeing advances in medical technology, disease prevention and treatment that can save lives and improve the general health of Americans, further proof that science is always a good investment.

The Scientist- Your Guide to NIH Stimulus Funds

Slate.com – America’s Got Science Talent